Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.

Objective: To compare tolterodine with oxybutynin and placebo in people with neurogenic detrusor overactivity.

Design: Prospective, randomized, double-blind, crossover trial plus open-label comparative stage.

Participants: Ten participants with neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis who used intermittent catheterization.